Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control

M Bassetti, E Righi, A Carnelutti… - Expert review of anti …, 2018 - Taylor & Francis
Introduction: Management of antimicrobial resistance in multi-drug-resistant-Klebsiella
pneumoniae (MDR-KP) is a major challenge for clinicians. The optimal treatment option for …

New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae

A Russo, P Fusco, HL Morrone… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction The management of multidrug-resistant (MDR) Klebsiella pneumoniae (KP)
represents a major challenge in the field of infectious diseases. It is associated with a high …

Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy

D Loconsole, M Accogli, AL De Robertis… - Annals of Clinical …, 2020 - Springer
Abstract Background Carbapenem-resistant Klebsiella pneumoniae (CR-KP) is an urgent
public health issue in Italy. This pattern of resistance is due mainly to dissemination of …

Characterization of Klebsiella pneumoniae Coproducing KPC and NDM-1 Carbapenemases from Turkey

A Tekeli, İ Dolapci, E Evren, E Oguzman… - Microbial Drug …, 2020 - liebertpub.com
Aims: The emergence of multidrug-resistant and carbapenem-resistant Klebsiella
pneumoniae has became a major public health threat. In this study, we describe the …

Genomic Characterization of KPC-31 and OXA-181 Klebsiella pneumoniae Resistant to New Generation of β-Lactam/β-Lactamase Inhibitor Combinations

N Muresu, A Del Rio, V Fox, R Scutari, C Alteri, BM Are… - Antibiotics, 2022 - mdpi.com
Background: Carbapenem resistant Klebsiella pneumoniae (cr-Kp) causes serious
infections associated with a high mortality rate. The clinical efficacy of ceftazidime/avibactam …

[HTML][HTML] Carbapenem-Resistant Enterobacterales

HZ Smith, CM Hollingshead, B Kendall - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Select appropriate treatment options for a patient with carbapenem-resistant
Enterobacterales infections. Identify the reasons for a delayed diagnosis of carbapenem …

Fecal Carriage and Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Hospitalized Patients in a University Hospital

Q Liu, L Liu, Y Li, X Chen, Q Yan… - Infection and drug …, 2019 - Taylor & Francis
Purpose To determine the prevalence and epidemiology of fecal carriage of carbapenem-
resistant Enterobacteriaceae (CRE), antimicrobial susceptibility, carbapenemase …

A Whole-Genome Sequencing-Based Approach for the Characterization of Klebsiella pneumoniae Co-Producing KPC and OXA-48-like Carbapenemases Circulating …

A Del Rio, V Fox, N Muresu, I Sechi, A Cossu… - Microorganisms, 2023 - mdpi.com
Background: Whole-genome sequencing (WGS) provides important information for the
characterization, surveillance, and monitoring of antimicrobial resistance (AMR) …

[HTML][HTML] Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and associated clinical outcomes

G Dai, Y Xu, H Kong, W Xie, H Wang - American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: To evaluate the risk factors and clinical outcomes of carbapenem-resistant
Klebsiella pneumoniae (K. pneumoniae)(CRKP) infection. Materials and Methods: A case …

Novel Target Exploration from Hypothetical Proteins of Klebsiella pneumoniae MGH 78578 Reveals a Protein Involved in Host-Pathogen Interaction

G Pranavathiyani, J Prava, AC Rajeev… - Frontiers in Cellular and …, 2020 - frontiersin.org
The opportunistic pathogen Klebsiella pneumoniae is a causative agent of several hospital-
acquired infections. It has become resistant to a wide range of currently available antibiotics …